EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis
Abstract Background Hepatitis B virus (HBV)-encoded X antigen, HBx, assists in the development of hepatocellular carcinoma (HCC) through complex mechanisms. Our results provide new insights into the EZH2 epigenetic repression of let-7c that promotes HCC migration induced by HBx. Thus, let-7c and HMG...
Main Authors: | Chen-Shiou Wu, Yi-Chung Chien, Chia‐Jui Yen, Jia-Yan Wu, Li-Yuan Bai, Yung-Luen Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-023-03002-9 |
Similar Items
-
EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
by: Bohan Wang, et al.
Published: (2023-06-01) -
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
by: Shaofei Chen, et al.
Published: (2018-01-01) -
HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2
by: Yafei Ye, et al.
Published: (2019-09-01) -
Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
by: Sarah Brunty, et al.
Published: (2021-03-01) -
SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters
by: Elisabeth Groß, et al.
Published: (2023-06-01)